FindTrial
Sign In

Using blood investigation to predict mechanical ventilation prediction in Neuromuscular disease(Gullian Barre syndrome) patients admitted in ICU

Predictive role of Immune-Nutritional Indices and Muscle atrophy in determining ventilator management outcomes in Guillain-Barre Syndrome (GBS) Patients in the intensive care unit - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076173
Enrollment
50
Registered
2024-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G610- Guillain-Barre syndrome

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Shweta S Naik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18 – 75 years 2. GBS patients admitted to ICU

Exclusion criteria

Exclusion criteria: 1. Patients with trauma to lower limbs 2. Unable to get an ultrasound image 3. Refusal to give consent 4. Pregnancy

Design outcomes

Primary

MeasureTime frame
1.To evaluate the predictive value of baseline immune-nutritional indices for muscle mass change in Guillain-Barre Syndrome (GBS) patients requiring mechanical ventilation.Timepoint: blood investigation done at baseline will be taken. muscle ultrasound at day 0, day 3 and discharge will be done—

Secondary

MeasureTime frame
2. To determine the influence of immune-nutritional indices on ventilator management outcomes (tracheostomy, extubation, or non-intubation) in Guillain-Barre Syndrome patientsTimepoint: blood investigation done at baseline will be taken. muscle ultrasound at day 0, day 3, day 7 and discharge will be done—

Countries

India

Contacts

Public ContactDr Shweta S Naik

National Institute of Mental Health and Neurosciences

neurodocms@gmail.com9480829837

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026